Pfizer's COVID-19 treatment pill Paxlovid was the first pill authoriSed in the U-S to treat coronavirus. But since its approval, there have been questions as to why it takes so long to make.
Share
Why is Pfizer's rollout of its anti-COVID pill so slow?
In this photo provided by Pfizer, a lab technician visually inspects Paxlovid tablet samples in Freiburg, Germany in December 2021. Studies showed that the first pill to treat the virus led to a nearly 90% reduction in hospitalizations and deaths among patients most likely to get severe disease. (Pfizer via AP) Credit: thomas hansmann.fotograf/AP
Pfizer's COVID-19 treatment pill Paxlovid was the first pill authoriSed in the U-S to treat coronavirus. But since its approval, there have been questions as to why it takes so long to make.
Published
By Tina Quinn
Source: SBS News
Share this with family and friends
Latest podcast episodes
Queensland children under five to be removed from residential state care
podcast episode7 minutes 29 seconds
Trump’s Bibi tirade, Hegseth peddles used subs &… lucky testicles?
podcast episode35 minutes 16 seconds
Garbage, water crisis engulfs Havana as US pressure and fuel blockade bites
podcast episode6 minutes 23 seconds
Racial furore erupts after video emerges of UK police handcuffing dying stab victim
podcast episode5 minutes 4 seconds
